Category: by journal

Second paper tied to drug scandal in Norway ski team retracted

Researchers in Norway have retracted a second high-profile exercise paper — again after running afoul of an ethical approval committee.

As part of the 2016 study, the researchers gave athletes asthma medication to measure its effect on signals from the nervous system to the lungs; although the drug appeared to have no detectable effect on the nervous system signals, 45 minutes after getting the drug, athletes (including those without asthma) showed an average slight increase in one measure of lung function.

Annette Birkeland, of The Norwegian National Research Ethics Committees (FEK), told us:

Continue reading Second paper tied to drug scandal in Norway ski team retracted

Journal retracts paper after discovering lead author forged co-author’s signature

A pharmacy journal has retracted a 2017 cancer paper after determining that the lead author forged her co-author’s signature.

Alain Li Wan Po, editor-in-chief of the Journal of Clinical Pharmacy and Therapeutics, told Retraction Watch that, after discovering the forgery, the journal lost confidence in “the integrity of the whole report,” and decided to retract it:

Our judgment was that if an author is willing to forge a signature, we cannot be sure of the integrity of the whole report and decided on the retraction.

According to Po, the paper’s lead author, Yan Wang, objected to the retraction because “she maintained that the data were accurate.” So the editors retracted the paper without her approval — but with the agreement of the author Jatinder Lamba, whose name was forged.

How did the journal discover the forged signature?

Continue reading Journal retracts paper after discovering lead author forged co-author’s signature

Caught Our Notice: Oops, wrong species

Title: Virulent Diuraphis noxia Aphids Over-Express Calcium Signaling Proteins to Overcome Defenses of Aphid-Resistant Wheat Plants

What Caught Our Attention: Sadly, it’s not uncommon for researchers to mistake the identity of what they’re working with — but not everyone comes clean and works to transparently correct the record. So it’s nice to see some authors among a group based in the US and India take the initiative to retract their paper after realizing they had based some of their conclusions on the wrong species of aphid. Continue reading Caught Our Notice: Oops, wrong species

“GOOD NEWS!…we were able to retract your article:” Journal

A paleontology journal has retracted a recent paper after discovering it had published the uncorrected version of the manuscript.

The mistake occurred after the authors submitted revisions to the manuscript without tracking the changes, prompting the publisher to believe nothing had been changed and publishing the previous version. The journal initially told the authors it planned to publish an erratum that described the mistake as a production error, but then retracted the paper—seemingly without consulting the authors. However, the authors said they were happy with the outcome.

Glenn Brock, an author on the Journal of Paleontology paper, told Retraction Watch: Continue reading “GOOD NEWS!…we were able to retract your article:” Journal

“The most terrible experience of my life:” Authorship dispute leads to lawsuit

A journal has retracted a 2014 paper because of an authorship dispute that became the subject of litigation.

Last year, the Allegheny Health Network in Pittsburgh requested the paper be retracted to resolve the dispute. The Journal of Applied Biomaterials & Functional Materials retracted the paper in October.

According to the retraction notice, the principal investigator of a clinical trial on which some of the study is based was not included as a co-author, and claimed he had not “validated the accuracy of the data.”

The notice does not mention a lawsuit, but a letter from the authors’ research institution does.

Continue reading “The most terrible experience of my life:” Authorship dispute leads to lawsuit

Researcher at Japan stem cell institute falsified nearly all images in 2017 paper

Shinya Yamanaka

An investigation by Kyoto University in Japan has found a researcher guilty of falsifying all but one of the figures in a 2017 stem cell paper.

Yesterday, Kyoto University announced that the paper’s first author, Kohei Yamamizu, had fabricated and falsified data in the Stem Cell Reports paper. According to the investigation report, none of the other authors were involved in the data manipulation.

Yamamizu works at the Center for iPS cell Research and Application (CiRA) at Kyoto University, directed by Shinya Yamanaka, a Nobel Prize winner for his pioneering work in stem cell biology.

A spokesperson for the journal told us that the authors disclosed the problems last week and Stem Cell Reports will be retracting the paper, published last February.

In the university’s official statement, Yamanaka said: Continue reading Researcher at Japan stem cell institute falsified nearly all images in 2017 paper

Author under fire on PubPeer issues puzzling correction to chem paper

A researcher whose work has been heavily questioned on PubPeer has corrected a figure on a 2015 paper in Talanta — but the text of the correction doesn’t match the actual changes.

Recently, Rashmi Madhuri at the Indian Institute of Technology (Indian School of Mines) in Dhanbad corrected a 2015 paper about a diagnostic sensor that uses nanoparticles, noting that there was a “small error” in the legend describing figure 1. But the corrected image bears the same legend it had before, and instead swapped a panel of the figure that had been questioned on PubPeer.

Here’s another puzzling element to the story: Gary Christian at the University of Washington, one of the editors-in-chief of the journal, tells us he doesn’t “recall being aware of the corrigendum:”

Continue reading Author under fire on PubPeer issues puzzling correction to chem paper

Author retracts 2009 chemistry paper with “heavily doctored” images

A researcher has retracted a 2009 chemistry paper after discovering that a figure had been “inappropriately edited.”

According to the journal, a reader brought the images in question in Figure 1 to the editors’ attention last September. Timothy P. Lodge, distinguished professor at the University of Minnesota in Minneapolis — and editor of Macromolecules through December 2017 — told Retraction Watch:

Continue reading Author retracts 2009 chemistry paper with “heavily doctored” images

Indexing company praises cancer journal, then kicks it out

A company that indexes journals — which, in turn, designates their impact factors — has delisted Oncotarget, a cancer journal that was recently removed from MEDLINE.

Just three months ago, on October 18, the indexing company Clarivate Analytics (formerly part of Thomson Reuters) named Oncotarget a “rising star” in the field of molecular biology and genetics.

News of the Clarivate delisting has been circulating on Chinese-language blogs, and Oncotarget acknowledged what happened on its own website:

Continue reading Indexing company praises cancer journal, then kicks it out

“A painful lesson:” Authors retract paper after discovering mislabeled mouse lines

Neuroscientists have retracted a 2016 paper examining the genetic underpinnings of a degenerative motor neuron disease, after discovering that two mouse lines had been accidentally mislabeled.

According to the retraction notice, published in December in Acta Neuropathologica Communications, mice engineered to have a specific genetic mutation were mislabeled as the normal or wild type group.

The notice cites an investigation by the University of Florida; we asked the university for a copy of the report. The university sent us a redacted document, which a spokesperson told us was a self-report from the researchers regarding the mislabeling. The spokesperson explained: Continue reading “A painful lesson:” Authors retract paper after discovering mislabeled mouse lines